New users of sodium-glucose cotransporter 2 inhibitors are at low risk of incident pancreatic cancer: a nationwide population-based cohort study

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8ff4cf0b6d9eebe4-LAX IP: 116.62.10.13 UTC time: 2025-01-09T13:35:08+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4